EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Detectable plasma severe acute respiratory syndrome coronavirus 2 spike antigen is associated with poor antibody response following third messenger RNA vaccination in kidney transplant recipients

Andrew H Karaba iD, Zoe Swank, Sarah Hussain, Margaret Chahoud, Christine M Durand, Dorry L Segev, Mark A Robien, Peter S Heeger, Christian P Larsen, Aaron A R Tobian iD, David R Walt, William A Werbel iD

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Andrew H Karaba und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Spike Glycoprotein, Coronavirus, Antibodies, Viral, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kidney transplant recipients (KTRs) generate lower antibody responses to messenger RNA (mRNA)‐based severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination, yet precise mechanisms for this poor response remain uncertain. One potential contributor is suboptimal spike antigen (sAg) translation and expression owing to transplant immunosuppression, which might lead to insufficient exposure to develop humoral and/or cellular immune responses.

Methods

Within a single‐arm clinical trial, 65 KTRs underwent ultrasensitive plasma sAg testing before, and 3 and 14 days after, the third mRNA vaccine doses. Anti‐SARS‐CoV‐2 spike antibodies (anti‐receptor binding domain [anti‐RBD]) were serially measured at 14 and 30 days post‐vaccination. Associations between sAg detection and clinical factors were assessed. Day 30 anti‐RBD titer was compared among those with versus without sAg expression using Wilcoxon rank sum testing.

Results

Overall, 16 (25%) KTRs were sAg positive (sAg+) after vaccination, peaking at day 3. Clinical and laboratory factors were broadly similar in sAg(+) versus sAg(‐) KTRs. sAg(+) status was significantly negatively associated with day 30 anti‐RBD response, with median (interquartile range) 10.8 (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationSpike Glycoprotein, CoronavirusAntibodies, ViralSARS-CoV-2COVID-19COVID-19 VaccinesTransplant RecipientsHumansMaleFemaleMiddle AgedAdultAgedAntibody FormationVaccinationBNT162 Vaccine

Stichwörter der Autor:innen

SARS‐CoV‐2antibody responsespike antigentransplantvaccination

Substanzen

Spike Glycoprotein, CoronavirusAntibodies, Viralspike protein, SARS-CoV-2COVID-19 VaccinesBNT162 Vaccine

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA.
  • Department of Surgery, NYU Grossman School of Medicine, New York, New York, USA.
  • Transplantation Branch, Division of Allergy Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.

ORCID-Profile: Andrew H Karaba, Aaron A R Tobian, William A Werbel

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Karaba, A. H., Swank, Z., Hussain, S., Chahoud, M., Durand, C. M., Segev, D. L., Robien, M. A., Heeger, P. S., Larsen, C. P., Tobian, A. A. R., Walt, D. R., & Werbel, W. A. (2024). Detectable plasma severe acute respiratory syndrome coronavirus 2 spike antigen is associated with poor antibody response following third messenger RNA vaccination in kidney transplant recipients. Transplant Infectious Disease. https://doi.org/10.1111/tid.14281

Vancouver

Karaba AH, Swank Z, Hussain S, Chahoud M, Durand CM, Segev DL, et al. Detectable plasma severe acute respiratory syndrome coronavirus 2 spike antigen is associated with poor antibody response following third messenger RNA vaccination in kidney transplant recipients. Transplant Infectious Disease. 2024. doi:10.1111/tid.14281

BibTeX
@article{Karaba2024,
  author = {Karaba, Andrew H and Swank, Zoe and Hussain, Sarah and Chahoud, Margaret and Durand, Christine M and Segev, Dorry L and Robien, Mark A and Heeger, Peter S and Larsen, Christian P and Tobian, Aaron A R and Walt, David R and Werbel, William A},
  title = {Detectable plasma severe acute respiratory syndrome coronavirus 2 spike antigen is associated with poor antibody response following third messenger RNA vaccination in kidney transplant recipients},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14281}
}
Kostenlos starten →